Core Scientific, Inc./tx (CORZ) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | $278.25M | +548.7% |
| 2024 | $42.90M | -34.1% |
| 2023 | $65.11M | -68.3% |
| 2022 | $205.19M | +461.7% |
| 2021 | -$56.73M | -138.7% |
| 2020 | -$23.77M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | $278.25M | +548.7% |
| 2024 | $42.90M | -34.1% |
| 2023 | $65.11M | -68.3% |
| 2022 | $205.19M | +461.7% |
| 2021 | -$56.73M | -138.7% |
| 2020 | -$23.77M | — |